Cancer Research Annual Meeting 2010  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 5663-5669, November 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horton, M. A.
Right arrow Articles by Chambers, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horton, M. A.
Right arrow Articles by Chambers, T. J.

Monoclonal Antibodies to Osteoclastomas (Giant Cell Bone Tumors): Definition of Osteoclast-specific Cellular Antigens1

Michael A. Horton2, Denise Lewis, Katrina McNulty, Jean A. S. Pringle and Tim J. Chambers

Departments of Haematology [M. A. H., D. L., K. M.] and Histopathology [T. J. C.], St. Bartholomew's Hospital, London, and Department of Morbid Anatomy [J. A. S. P.], Institute of Orthopaedics, Royal National Orthopaedic Hospital, Stanmore, Middlesex, United Kingdom

The cellular origin of the osteoclast, the major agent of bone resorption, remains controversial despite the demonstration that osteoclasts form by fusion of mononuclear cells that are ultimately derived from a bone marrow stem cell. One view is that they are the terminally differentiated progeny of mononuclear phagocytic cells. However, we have previously provided evidence, from functional and phenotypic studies of rodent and human osteoclasts, that raises the possibility that osteoclasts form a separate cell lineage from conventional hemopoietic cells and macrophages in particular. In an attempt to elucidate this question, we have used monoclonal antibody techniques to examine the relationship between osteoclasts and other bone marrow-derived cells. By using osteoclasts from osteoclastomas (giant cell tumors of bone) for immunizations, we have produced 11 mouse hybridomas secreting monoclonal antibodies reacting with osteoclasts in normal human fetal bone and a variety of neoplastic and non-neoplastic bone lesions. Eight antibodies in 4 reactivity sets have been shown to recognize membrane antigens, whereas a further 3 react with cytoplasmic determinants. In 7 there is no cross-reactivity with macrophages in a wide range of tissues, thus effectively differentiating between these two cell types. These antibodies will prove useful for the identification of osteoclasts in tissues and in the separation of their circulating precursors, thus allowing an experimental approach to be made to many of the outstanding questions regarding the developmental pathobiology of the osteoclast.

1 Supported in part by grants from the Arthritis and Rheumatism Council, Cancer Research Campaign, and Wellcome Trust.

2 Reimbursed I.C.R.F. Senior Lecturer in Haematology. To whom requests for reprints should be addressed.

Received 3/ 7/85. Revised 8/ 1/85. Accepted 7/ 5/85.




This article has been cited by other articles:


Home page
J. Virol.Home page
H. Duque, M. LaRocco, W. T. Golde, and B. Baxt
Interactions of Foot-and-Mouth Disease Virus with Soluble Bovine {alpha}V{beta}3 and {alpha}V{beta}6 Integrins
J. Virol., September 15, 2004; 78(18): 9773 - 9781.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
T. Hirayama, L. Danks, A. Sabokbar, and N. A. Athanasou
Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis
Rheumatology, November 1, 2002; 41(11): 1232 - 1239.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
S.D. Neale, E. Schulze, R. Smith, and N.A. Athanasou
The influence of serum cytokines and growth factors on osteoclast formation in Paget's disease
QJM, April 1, 2002; 95(4): 233 - 240.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-H. Han, S. J. Choi, N. Kurihara, M. Koide, Y. Oba, and G. D. Roodman
Macrophage inflammatory protein-1{alpha} is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor {kappa}B ligand
Blood, June 1, 2001; 97(11): 3349 - 3353.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
C Faucheux, S Nesbitt, M Horton, and J Price
Cells in regenerating deer antler cartilage provide a microenvironment that supports osteoclast differentiation
J. Exp. Biol., January 2, 2001; 204(3): 443 - 455.
[Abstract] [PDF]


Home page
BloodHome page
S. J. Choi, J. C. Cruz, F. Craig, H. Chung, R. D. Devlin, G. D. Roodman, and M. Alsina
Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma
Blood, July 15, 2000; 96(2): 671 - 675.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
L. Levy, S. Broad, D. Diekmann, R. D. Evans, and F. M. Watt
beta 1 Integrins Regulate Keratinocyte Adhesion and Differentiation by Distinct Mechanisms
Mol. Biol. Cell, February 1, 2000; 11(2): 453 - 466.
[Abstract] [Full Text]


Home page
Ann Rheum DisHome page
I Itonaga, A Sabokbar, D W Murray, and N A Athanasou
Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages
Ann Rheum Dis, January 1, 2000; 59(1): 26 - 31.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
M. Triantafilou, K. Triantafilou, K. M. Wilson, Y. Takada, N. Fernandez, and G. Stanway
Involvement of {beta}2-microglobulin and integrin {alpha}v{beta}3 molecules in the coxsackievirus A9 infectious cycle
J. Gen. Virol., October 1, 1999; 80(10): 2591 - 2600.
[Abstract] [Full Text]


Home page
FASEB J.Home page
V. EVERTS, W. KORPER, D. C. JANSEN, J. STEINFORT, I. LAMMERSE, S. HEERA, A. J. P. DOCHERTY, and W. BEERTSEN
Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone
FASEB J, July 1, 1999; 13(10): 1219 - 1230.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
K. Matsuzaki, K. Katayama, Y. Takahashi, I. Nakamura, N. Udagawa, T. Tsurukai, R. Nishinakamura, Y. Toyama, Y. Yabe, M. Hori, et al.
Human Osteoclast-Like Cells Are Formed from Peripheral Blood Mononuclear Cells in a Coculture with SaOS-2 Cells Transfected with the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor Gene
Endocrinology, February 1, 1999; 140(2): 925 - 932.
[Abstract] [Full Text]


Home page
Ann Rheum DisHome page
A. Sabokbar, Y. Fujikawa, S. Neale, D. W Murray, and N. A Athanasou
Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells
Ann Rheum Dis, July 1, 1997; 56(7): 414 - 420.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Katada, Y. Hayashi, Y. Sato, M. Muramatsu, Y. Takiguchi, T. Harada, T. Fujiyoshi, and I. Uno
A Novel Peptide Motif for Platelet Fibrinogen Receptor Recognition
J. Biol. Chem., March 21, 1997; 272(12): 7720 - 7726.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
N. A. ATHANASOU
Current Concepts Review - Cellular Biology of Bone-Resorbing Cells
J. Bone Joint Surg. Am., July 1, 1996; 78(7): 1096 - 1112.
[Full Text]


Home page
J. Cell Sci.Home page
G Zambruno, P. Marchisio, A Melchiori, S Bondanza, R Cancedda, and M De Luca
Expression of integrin receptors and their role in adhesion, spreading and migration of normal human melanocytes
J. Cell Sci., January 5, 1993; 105(1): 179 - 190.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
N. Kurihara, C. Menaa, H. Maeda, D. J. Haile, and S. V. Reddy
Osteoclast-stimulating Factor Interacts with the Spinal Muscular Atrophy Gene Product to Stimulate Osteoclast Formation
J. Biol. Chem., October 26, 2001; 276(44): 41035 - 41039.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.